Key result
Edoxaban was non-inferior to warfarin for the prevention of stroke and systemic embolism among patients with atrial fibrillation, with significantly lower rates of major bleeding.
Why the study?
Does edoxaban improve outcomes compared to warfarin in patients with atrial fibrillation on amiodarone?
Population
Patients with atrial fibrillation on amiodarone
Comparison
Edoxaban vs Warfarin
Design
Editorial
Authors
Loading...
This editorial discusses the interactions between edoxaban and amiodarone in patients with atrial fibrillation based on a subgroup analysis of the ENGAGE AF-TIMI 48 trial.
Does edoxaban improve outcomes compared to warfarin in patients with atrial fibrillation on amiodarone?
This editorial discusses the interactions between edoxaban and amiodarone in patients with atrial fibrillation based on a subgroup analysis of the ENGAGE AF-TIMI 48 trial.
David Conen (2015) conducted an editorial in Atrial fibrillation. Edoxaban vs. Warfarin was evaluated on Stroke and systemic embolism. Edoxaban was non-inferior to warfarin for the prevention of stroke and systemic embolism among patients with atrial fibrillation, with significantly lower rates of major bleeding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: